Lung Cancer in New Zealand – The Facts

Dear Supporter Lung cancer kills more people in New Zealand every year, than breast cancer, prostate cancer and melanoma cancer combined, yet it is the least funded.  Right now, we are witnessing unprecedented suffering and inequity in New Zealand, resulting in premature death for the majority of patients diagnosed with lung cancer. Sadly, almost 1900 […]

Sign our Petition

Please stand with us by signing this petition. Together we can call on the Government to declare lung cancer a health priority and to approve additional budget for Pharmac to fund lung cancer medications, including Keytruda, Alectinib, Osimertinib and Crizotinib, for all Kiwis with advanced lung cancer, irrespective of socio-economic status. https://www.parliament.nz/en/pb/petitions/document/PET_86322/petition-of-philip-hope-for-lung-foundation-new-zealand?fbclid=IwAR0Er6gNod70xvpB1kq3bBVa0LExrfq8GSWo7Gv3KvV-Jr9vwb8mL-NsrDs

Submission to Pharmac – includes letters from lung cancer patients

Lung Foundation NZ has filed a submission with Pharmac, urging them to do better for lung cancer – NZ’s Biggest Cancer Killer. A staggering imbalance exists, because of underfunding by Pharmac. For example; the top 3 lung cancer drugs reimbursed in NZ, represents less than 3% of the top 5 cancer drugs funded, despite lung […]

Courageous mother of two talks about her lung cancer journey

Christine Roberts, 51, was diagnosed with stage four lung cancer in May 2017. This brave mother talks about her challenging cancer journey and her children. Christine has a message for Pharmac which is an instrument of government. http://https://drive.google.com/file/d/1QwSf4swQXLDNA4M9qVmUHhsuZNv0lsU-/view

National lung cancer screening programme could save kiwi lives

The introduction of a lung cancer screening programme has the potential to improve health outcomes in New Zealand for NZ’s Biggest Cancer Killer. Data from the NELSON study which was presented at last year’s International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer (to which Lung Foundation NZ is affiliated) […]

New Zealanders are dying – so why the delay on KEYTRUDA?

Monday 19th November 2018 – Following a historic decision by Australia to fund untreated lung cancer patients, Lung Foundation New Zealand says it is extremely disappointed that Pharmac has made no decision on KEYTRUDA two years after making a funding application. 2018 19th November – Lung Foundation Media Release